<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CLOXACILLIN, SODIUM</span><br/>(klox-a-sill'in)<br/><span class="topboxtradename">Apo-Cloxi <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Cloxapen, </span><span class="topboxtradename">Cloxilean, </span><span class="topboxtradename">Novocloxin <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Orbenin, </span><span class="topboxtradename">Tegopen<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic, natural penicillin</span>; <span class="classification">beta-lactam</span><br/><b>Prototype: </b>Penicillin G<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>250 mg, 500 mg capsules; 125 mg/5 mL oral suspension</p>
<h1><a name="action">Actions</a></h1>
<p>Semisynthetic, acid-stable, penicillinase-resistant, isoxazolyl penicillin. Effective against most gram-positive bacteria.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>In common with other isoxazolyl penicillins (dicloxacillin, oxacillin), highly active against most penicillinase-producing
         staphylococci, less potent than penicillin G against penicillin-sensitive microorganisms, and generally ineffective against
         gram-negative bacteria and methicillin-resistant staphylococci (MRSA).
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Primarily in infections caused by penicillinase-producing staphylococci and penicillin-resistant staphylococci. May be used
         to initiate therapy in suspected staphylococcal infections pending culture and susceptibility test results. As with other
         penicillins, serum concentrations are enhanced by concurrent use of probenecid.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Sensitivity to penicillins; pregnancy (category B), lactation. Safe use in neonates not established.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>History of or suspected atopy or allergy (asthma, eczema, hives, hay fever), renal or hepatic function impairment, history
         of allergy to cephalosporins.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Mild to Moderate Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 250500 mg q6h<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> </td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give on an empty stomach (at least 1 h before or 2 h after meals) unless otherwise advised by physician. Food reduces rate
            and extent of drug absorption.
         </li>
<li>After reconstitution PO solution retains potency for 14 d if refrigerated (shake well before pouring).</li>
<li>Unless otherwise advised, store capsules at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Wheezing, sneezing, chills, drug fever, <span class="speceff-life">anaphylaxis</span>, superinfections. <span class="typehead">GI:</span>
<span class="speceff-common">Nausea,</span> vomiting, flatulence, <span class="speceff-common">diarrhea</span>. <span class="typehead"> Hematologic:</span> Eosinophilia, leukopenia, <span class="speceff-life">agranulocytosis</span>. <span class="typehead"> Metabolic:</span>  Elevated AST, ALT; jaundice (possibly of allergic etiology). <span class="typehead">Skin:</span> Pruritus, urticaria, rash. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Probenecid</b> decreases cloxacillin elimination. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 3760% absorbed from GI tract. <span class="typehead">Peak:</span>  0.52 h. <span class="typehead"> Duration:</span>  46 h. <span class="typehead">Distribution:</span> Distributed throughout body with highest concentrations in liver, kidney, spleen, bone, bile, and pleural fluid; low CSF penetration;
      crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted primarily in urine with some elimination through bile. <span class="typehead">Half-Life:</span> 3060 min. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Determine previous exposure and sensitivity to penicillins and cephalosporins and other allergic reactions of any kind before
            treatment is initiated.
         </li>
<li>Monitor for S&amp;S of anaphylactoid reaction (see Appendix G) or other signs or symptoms of hypersensitivity reaction (see Appendix
            F) as with other penicillins.
         </li>
<li>Lab tests: Periodic assessments of renal, hepatic, and hematopoietic function are advised in patients on long-term therapy.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take medication around the clock, do not miss a dose, and continue taking the medication until it is finished.</li>
<li>Report to physician the onset of hypersensitivity reaction (see Appendix F) and superinfections.</li>
<li>Check with physician if GI adverse effects (nausea, vomiting, diarrhea) appear.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>